Skip to main content
    D

    Dyne Therapeutics Inc (DYN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $16.70
    -0.46 (-2.68%)

    Market Cap: $3.22B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Dyne Therapeutics Inc (DYN) Earnings: Report Dates and Results

    Updated Nov 5, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Dyne Therapeutics (DYN) is expected to report earnings on Mar 1, 2027. In the quarter ended Sep 30, 2026, Dyne Therapeutics reported EPS of -$1.06, below the -$0.88 estimate. It beat the EPS estimate in 4 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    39%(11/28)
    Avg Surprise
    -11.72%

    Upcoming Estimates

    Reports Mar 1, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.99
    Range-$1.06 - -$0.89
    17 analysts
    Revenue Consensus
    N/A
    RangeN/A
    16 analysts
    Reports May 10, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$1.00
    Range-$1.08 - -$0.91
    6 analysts
    EPS Revisions
    1
    2
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.80-25.3%
    60d ago-$0.80-25.3%
    30d ago-$0.84-19.2%
    7d ago-$0.84-19.2%
    Current-$1.00
    Revenue Consensus
    $3.00M
    Range$125.00K - $8.95M
    6 analysts

    Next Report

    DYN has an expected report date of Mar 1, 2027.

    Earnings History

    Of the 30 quarters below that had an estimate, DYN beat 11 and missed 19. The widest gap in the table came in the quarter ended Sep 30, 2016, when EPS landed 242.86% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$1.06-$0.88-$1.09 - -$0.65-20.45%MissN/A141 up, 1 downNov 5, 2026N/A
    Jun 30, 2026-$1.08-$0.74-$0.84 - -$0.62-45.95%MissN/A145 up, 5 downJul 27, 2026N/A
    Mar 31, 2026-$0.73-$0.78-$1.08 - -$0.64+6.41%BeatN/A105 up, 1 downMay 11, 2026N/A
    Dec 31, 2025-$0.73-$0.77-$0.94 - -$0.59+5.48%BeatN/A101 up, 0 downMar 2, 2026N/A
    Sep 30, 2025-$0.76-$0.81-$1.14 - -$0.64+6.17%BeatN/A111 up, 0 downNov 5, 2025N/A
    Jun 30, 2025-$0.97-$0.93-$1.14 - -$0.62-4.30%MissN/A131 up, 1 downJul 28, 2025N/A
    Mar 31, 2025-$1.05-$0.84-$1.07 - -$0.52-25.00%MissN/A102 up, 4 downMay 8, 2025N/A
    Dec 31, 2024-$0.88-$0.91-$1.23 - -$0.67+3.51%BeatN/A90 up, 5 downFeb 27, 2025$1.57M
    Sep 30, 2024-$0.96-$0.71-$0.80 - -$0.61-35.21%MissN/A100 up, 0 downNov 12, 2024N/A
    Jun 30, 2024-$0.70-$0.72-$0.97 - -$0.59+2.78%BeatN/A100 up, 0 downAug 12, 2024N/A
    Mar 31, 2024-$0.81-$0.80-$0.83 - -$0.75-1.25%MissN/A70 up, 0 downMay 2, 2024N/A
    Dec 31, 2023-$1.09-$0.93-$1.08 - -$0.73-17.20%MissN/A90 up, 0 downMar 5, 2024$3.79M
    Sep 30, 2023-$0.99-$0.76-$1.17 - -$0.59-30.26%MissN/A80 up, 0 downOct 30, 2023N/A
    Jun 30, 2023-$1.08-$0.78-$0.91 - -$0.68-38.46%MissN/A80 up, 0 downAug 3, 2023N/A
    Mar 31, 2023-$0.78-$0.76-$0.87 - -$0.67-2.63%MissN/A80 up, 0 downMay 11, 2023N/A
    Dec 31, 2022-$0.74-$0.84-$1.02 - -$0.67+11.90%BeatN/A80 up, 1 downMar 2, 2023N/A
    Sep 30, 2022-$0.80-$0.92-$1.01 - -$0.78+13.04%BeatN/A60 up, 0 downNov 3, 2022N/A
    Jun 30, 2022-$1.01-$0.80-$0.88 - -$0.69-26.25%MissN/A60 up, 0 downAug 4, 2022N/A
    Mar 31, 2022-$0.69-$0.88-$1.06 - -$0.74+21.59%BeatN/A40 up, 0 downMay 2, 2022N/A
    Dec 31, 2021-$1.00-$0.97-$1.06 - -$0.86-3.09%MissN/A40 up, 0 downMar 10, 2022N/A
    Sep 30, 2021-$0.83-$0.66-$0.70 - -$0.61-25.76%MissN/A40 up, 1 downNov 4, 2021N/A
    Jun 30, 2021-$0.58-$0.55-$0.61 - -$0.50-5.45%MissN/A4N/AAug 5, 2021N/A
    Mar 31, 2021-$0.50-$0.62-$0.68 - -$0.54+19.35%BeatN/A5N/AMay 6, 2021N/A
    Dec 31, 2020-$0.64-$0.37-$0.43 - -$0.32-72.97%MissN/A5N/AMar 4, 2021N/A
    Sep 30, 2020-$0.31-$0.39N/A+20.51%BeatN/AN/AN/ANov 5, 2020N/A
    Jun 30, 2020-$0.39N/AN/AN/AN/AN/AN/AN/ASep 17, 2020N/A
    Dec 31, 2017-$0.35-$0.42-$4.95 - $2.08+16.67%BeatN/A6N/AFeb 22, 2018$470.00M
    Sep 30, 2017$0.31$0.55$0.11 - $0.94-43.64%MissN/A6N/ANov 1, 2017$182.00M
    Jun 30, 2017-$1.12-$0.71-$1.33 - -$0.28-57.75%MissN/A5N/AAug 4, 2017$181.00M
    Mar 31, 2017-$1.24-$0.11N/AN/AN/AN/AN/AN/AMay 5, 2017$175.00M
    Dec 31, 2016-$1.40$0.14N/AN/AN/AN/AN/AN/AFeb 24, 2017$791.00M
    Sep 30, 2016-$0.30$0.21N/A-242.86%MissN/AN/AN/ANov 2, 2016$241.00M
    Jun 30, 2016-$1.36-$0.69N/A-97.10%MissN/AN/AN/AAug 4, 2016$166.00M
    Last 33 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$3.51, after -$3.35 the year before. It was -$3.06 for the year ended Dec 31, 2016, the oldest of the 8 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$3.51N/A
    Dec 31, 2024-$3.35N/A
    Dec 31, 2023-$3.94N/A
    Dec 31, 2022-$3.24N/A
    Dec 31, 2021-$2.91N/A
    Dec 31, 2020-$1.34N/A
    Dec 31, 2017-$2.40N/A
    Dec 31, 2016-$3.06N/A

    Frequently Asked Questions About DYN

    When is Dyne Therapeutics's next earnings date?

    Dyne Therapeutics's next earnings report is expected for Mar 1, 2027.

    Did DYN beat earnings estimates last quarter?

    No. Dyne Therapeutics reported EPS of -$1.06 for the quarter ended Sep 30, 2026, below the -$0.88 estimate by 20.45%.

    What EPS do analysts expect from DYN next quarter?

    The consensus EPS estimate for Dyne Therapeutics for the quarter ending Dec 31, 2026 is -$0.99 from 17 analysts, with estimates from -$1.06 to -$0.89.

    How often does DYN beat earnings estimates?

    Dyne Therapeutics beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -9.27%.